Transport of vitamin D3 from its sites of cutaneous synthesis into the circulation has been assumed to be via the plasma vitamin D binding protein (DBP). We studied vitamin D transport from the skin in seven healthy volunteers who received whole body irradiation with 27 mJ /cm2 dosage of ultraviolet B light (290-320 nm). Samples of venous blood were collected serially in EDTA and immediately chilled. In KBr, plasma samples were ultracentrifuged to provide a rapid separation of proteins of density < and > 1.3 g/ml. Upper and lower phases and serial fractions were analyzed for vitamin D3 (extraction, HPLC), cholesterol (enzyme assay), and human DBP (hDBP) (radial immunodiffusion). Total plasma vitamin D (basal level < 1 ng/ml) increased by 10 h and peaked at 24 h (9 ± 1 ng/ml). 98% of the D3 remained at the density > 1.3 layers for up to 7 d, whereas cholesterol (> 85%) was detected at density < 1.3 and all of the hDBP was at density > 1. Vitamin D is a precursor ofa renal steroid hormone, 1 ,25-dihydroxyvitamin D (1). This precursor, however, cannot be provided by enzymatic synthesis. Its supply depends on ultraviolet (UV) irradiation ofthe skin or absorption from the diet. Since few natural foodstuffs contain much vitamin D (2), observers consider the endogenous, cutaneous production of cholecalciferol to be the physiological mechanism of precursor supply (2-5).
Vitamin D is a precursor ofa renal steroid hormone, 1 ,25-dihydroxyvitamin D (1) . This precursor, however, cannot be provided by enzymatic synthesis. Its supply depends on ultraviolet (UV) irradiation ofthe skin or absorption from the diet. Since few natural foodstuffs contain much vitamin D (2), observers consider the endogenous, cutaneous production of cholecalciferol to be the physiological mechanism of precursor supply (2) (3) (4) (5) .
Distinct differences are recognized for the cutaneous synthesis vs. diet-derived supply of vitamin D (2, 6) . A more efficient and sustained supply of vitamin D is associated with UV irradiation of the skin or parenteral administration of vitamin D (2, 6) . In contrast, oral vitamin D consumption leads to rapid but less sustained availability of sterol and a similar pattern of increase in the hepatic metabolite, 25-hydroxycholecalciferol (2, (6) (7) (8) (9) .
Many studies have addressed the mode of vitamin D transport after oral consumption (6) , but no direct studies of the plasma transport of cutaneously-derived vitamin D are reported. It has been assumed that vitamin D synthesized in skin enters the blood stream on the plasma binding protein for vitamin D and its metabolites (DBP)' and this assumption is based on in vitro studies ofthe relative potency of vitamin D in binding to DBP as compared with 7-dehydroxycholesterol, lumisterol, tachysterols3 and pre-D3 (10) (11) (12) . However, other plasma carriers are recognized and some facilitate hepatic (13) (14) (15) and hepatocyte (16) Samplepreparation. Blood from volunteers was centrifuged within 1 h of collection in a refrigerated centrifuge. Plasma aliquots for total plasma vitamin D analysis were stored at -20'C. To carry out a rapid separation of plasma proteins of density less than and greater than 1.3 g/ml, the method of Chung et al. was used (17) . In brief, unfrozen plasma aliquots ( 1.5 ml) were dispensed into tubes containing preweighed KBr (513 mg). After mixing, plasma was added to 3.5 ml of 0.15 M NaCI in ultracentrifuge tubes before heat sealing. Tubes were centrifuged at 10'C in a Ti 65.2 vertical rotor at 65,000 rpm in an ultracentrifuge (model L8M; Beckman Instruments, Inc., Fullerton, CA) for 45 min. Fractions were collected via bottom punctures, permitting the isolation ofthe lower (30% of volume, density> 1.3 g/ml) and upper (70% of volume, density < 1.3 g/ml) phases.
Analyses. Quantitation of vitamins D3 and D2 was carried out as previously reported ( 18) . In brief, organic solvent extracts were applied to HPLC columns and the vitamin D fractions were quantitated by UV absorption spectrometry at 264 nm.
Cholesterol oxidase reagents were used to quantitate total cholesterol in ultracentrifuge fractions by visible spectrometry (Sigma kit).
DBP was quantitated in a radial immunodiffusion assay as reported earlier ( 19) .
Results
In pilot experiments to assess the validity and reproducibility of the plasma density separations in our laboratory, we analyzed total plasma content, as well as density less than and greater than 1.3 g/ml for DBP and cholesterol. For 16 separate human plasma samples, most ofthe DBP (89+2. 1%, SEM) and cholesterol (94+2.3%, SEM) in plasma was recovered in the density gradient fractions. Table I displays the upper and lower phase distribution of the substances after centrifugation. Fig. 1 depicts the distribution of DBP and cholesterol in continuous ultracentrifuge fractions of fasting human plasma. The DBP is contained in the lower third ofthe gradient, whereas the cholesterol profile reflects its association with several carriers, including some binding to high-density lipoproteins and density > 1.3 g/ml molecules ( 18) .
At baseline, total plasma cholecalciferol levels were < 2 mg/ml or undetectable (Fig. 2 A) . After irradiation, the total plasma cholecalciferol levels increased by 10 h, peaked at 24 h, and decreased by 3 and 7 d. Fig. 2 B depicts the distribution ofcholecalciferol in plasma before and after cutaneous irradiation. As shown, almost all of the baseline and postirradiation plasma cholecalciferol was associated with the fractions of density > 1.3 g/ml fractions.
After the oral dosage of vitamin D2, large increases in plasma vitamin D2 were observed (Fig. 3 A) . Baseline plasma D2 levels were undetectable in two subjects and 1 ng/ml plasma in the other subject. In contrast to the cutaneous irradiation supply of vitamin D3, the plasma vitamin D2 levels declined briskly toward baseline by 2 d.
The distribution of orally administered vitamin D2 in plasma was very different from that observed after cutaneous production of vitamin D3. As shown in Fig. 3 B, 41% of the plasma D2 was found in the fractions ofdensity < 1.3 g/ml at 4 h after the dose. This distribution in the lower density fractions decreased slightly by 8 and 24 h. After this large dose, it is clear that the vitamin is associated with low-and high-density carriers.
When plasma from UV light-treated subjects (24-h samples) was subjected to actin affinity chromatography to remove DBP (20) , all of the vitamin D was removed from these plasmas, indicating that the vitamin D was bound to DBP.
Discussion
Our results indicate that high density or nonlipoprotein carriers are responsible for the blood transport of recently synthesized, endogenous vitamin D3. Since the vitamin D3 was removed from these plasmas by actin affinity chromatography, the cutaneously produced vitamin D3 was bound to DBP as previously assumed (10) (11) (12) . Our data conform to the recognized, gradual egress ofcutaneously synthesized vitamin D3 (2, 6, 21, 22) , and underscore the differences between the cutaneous and dietary sources of the vitamin (2).
Diet-derived vitamin D requires the components of lipid absorption, as indicated by the association ofabsorbed vitamin D with chylomicron carriers in chyle (23) . When absorbed vitamin D reaches the subclavian vein, some of it is presented to the liver on the chylomicron remnants via specific receptormediated uptake and some redistributes to other plasma carriers such as DBP, lipoproteins, and albumin (6, 13, (24) (25) (26) . Since DBP is present in lymph and chyle, some ofthe absorbed vitamin D redistributes to DBP during chyle transport (26, 27) . The ( 15, 28) , intralipid ( 13) , plasma (29) , and oily depot injections (9) . In addition, although DBP is the only stereoselective plasma carrier of vitamin D, most of the other lower affinity carriers are in high concentration in plasma. When simply mixed with plasma directly, vitamin D does associate, to some extent, with non-DBP carriers ( 15 Since cutaneous production of vitamin D3 results in a gradual and more sustained plasma availability ofvitamin D and its bioactive product, 25-hydroxyvitamin D, this source is physiologically attuned to the recognized, intense economy of vitamin D stores (2, 6) . Rapid hepatic delivery of vitamin D can result in its waste with the appearance of inactive forms, including water-soluble conjugates (2). Our present results clearly indicate that DBP plays a central role in the physiological economy of cutaneously derived vitamin D3.
